These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32389219)

  • 1. Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.
    Trosman JR; Douglas MP; Liang SY; Weldon CB; Kurian AW; Kelley RK; Phillips KA
    Value Health; 2020 May; 23(5):551-558. PubMed ID: 32389219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination.
    Sheinson DM; Wong WB; Meyer CS; Stergiopoulos S; Lofgren KT; Flores C; Adams DV; Fleury ME
    JAMA Netw Open; 2021 Dec; 4(12):e2138219. PubMed ID: 34882180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.
    Trosman JR; Weldon CB; Kelley RK; Phillips KA
    J Natl Compr Canc Netw; 2015 Mar; 13(3):311-8. PubMed ID: 25736008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.
    Trosman JR; Weldon CB; Gradishar WJ; Benson AB; Cristofanilli M; Kurian AW; Ford JM; Balch A; Watkins J; Phillips KA
    Value Health; 2018 Sep; 21(9):1062-1068. PubMed ID: 30224110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment and private payers's coverage of personalized medicine.
    Trosman JR; Van Bebber SL; Phillips KA
    Am J Manag Care; 2011 May; 17 Suppl 5 Developing():SP53-60. PubMed ID: 21711078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Private Payer and Medicare Coverage for Circulating Tumor DNA Testing: A Historical Analysis of Coverage Policies From 2015 to 2019.
    Douglas MP; Gray SW; Phillips KA
    J Natl Compr Canc Netw; 2020 Jul; 18(7):866-872. PubMed ID: 32634780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing.
    Sheinson DM; Wong WB; Flores C; Ogale S; Gross CP
    JCO Oncol Pract; 2021 Nov; 17(11):e1774-e1784. PubMed ID: 34043456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS.
    Chambers JD; Saret CJ; Anderson JE; Deverka PA; Douglas MP; Phillips KA
    Int J Technol Assess Health Care; 2017 Jan; 33(4):534-540. PubMed ID: 29065945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?
    Phillips KA
    JAMA; 2018 Jun; 319(23):2379-2380. PubMed ID: 29710095
    [No Abstract]   [Full Text] [Related]  

  • 10. Private payers disagree with Medicare over medical device coverage about half the time.
    Chambers JD; Chenoweth M; Thorat T; Neumann PJ
    Health Aff (Millwood); 2015 Aug; 34(8):1376-82. PubMed ID: 26240252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical integration of next generation sequencing: coverage and reimbursement challenges.
    Deverka PA; Dreyfus JC
    J Law Med Ethics; 2014; 42 Suppl 1(Suppl 1):22-41. PubMed ID: 25298289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and spillover effects of private insurers' coverage of hepatitis C treatment.
    Moreno GA; Mulligan K; Huber C; Linthicum MT; Dreyfus D; Juday T; Marx SE; Gonzalez YS; Brookmeyer R; Lakdawalla DN
    Am J Manag Care; 2016 May; 22(6 Spec No.):SP236-44. PubMed ID: 27266954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
    Trosman JR; Weldon CB; Douglas MP; Kurian AW; Kelley RK; Deverka PA; Phillips KA
    J Natl Compr Canc Netw; 2017 Feb; 15(2):219-228. PubMed ID: 28188191
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of Centers for Medicare & Medicaid Services national coverage determination on erythropoiesis-stimulating agent and transfusion use in chemotherapy-treated cancer patients.
    Arneson TJ; Li S; Gilbertson DT; Bridges KR; Acquavella JF; Collins AJ
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):857-64. PubMed ID: 22450901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
    Deverka PA; Douglas MP; Phillips KA
    Value Health; 2020 May; 23(5):540-550. PubMed ID: 32389218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposal for a national coverage determination for the treatment of varicose veins and venous disease due to disparate Centers for Medicare and Medicaid Services local coverage determination policies.
    Welch HJ; Kabnick L; Vasquez MA; Monahan DL; Lurie F; Jacobowitz G
    J Vasc Surg Venous Lymphat Disord; 2017 May; 5(3):453-459. PubMed ID: 28411715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strengthening Multipayer Collaboration: Lessons From the Comprehensive Primary Care Initiative.
    Anglin G; Tu HA; Liao K; Sessums L; Taylor EF
    Milbank Q; 2017 Sep; 95(3):602-633. PubMed ID: 28895218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited.
    Douglas MP; Parker SL; Trosman JR; Slavotinek AM; Phillips KA
    Genet Med; 2019 Jan; 21(1):152-160. PubMed ID: 29997388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015.
    Desai NR; Bourdillon PM; Parzynski CS; Brindis RG; Spatz ES; Masters C; Minges KE; Peterson P; Masoudi FA; Oetgen WJ; Buxton A; Zipes DP; Curtis JP
    JAMA; 2018 Jul; 320(1):63-71. PubMed ID: 29971398
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.